All changes for the tissue brain (624)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA223
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member
Molecular
brain
Human
SERPINF1
7.0% Decrease Gene Expression Level
DAA216
seryl-tRNA synthetase
Molecular
brain
Human
SARS
10.0% Decrease Gene Expression Level
DAA236
transcription factor 12
Molecular
brain
Human
TCF12
7.0% Increase Gene Expression Level
DAA217
sodium channel, voltage-gated, type II, beta
Molecular
brain
Human
SCN2B
50.0% Decrease Gene Expression Level
DAA225
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
Molecular
brain
Human
SLC17A7
9.0% Decrease Gene Expression Level
DAA226
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
Molecular
brain
Human
SLC25A4
9.0% Decrease Gene Expression Level
DAA166
solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1
Molecular
brain
Human
SLC2A3P1
17.0% Decrease Gene Expression Level
DAA228
sorting nexin 3
Molecular
brain
Human
SNX3
5.0% Decrease Gene Expression Level
DAA766
Speech production problems
Psychological
brain
Human
—
—
DAA224
S-phase kinase-associated protein 1
Molecular
brain
Human
SKP1
4.0% Decrease Gene Expression Level
DAA67
sphingosine-1-phosphate receptor 1
Molecular
brain
Human
S1PR1
27.0% Increase Gene Expression Level
DAA230
spondin 1, extracellular matrix protein
Molecular
brain
Human
SPON1
21.0% Increase Gene Expression Level
DAA231
stathmin-like 2
Molecular
brain
Human
STMN2
6.0% Decrease Gene Expression Level
DAA627
Stroke
Pathological
brain
Human
—
SeriesMorbidity
DAA1027
Stroke (Female)
Pathological
brain
Human
—
SeriesIncidence
DAA1026
Stroke (Male)
Pathological
brain
Human
—
SeriesIncidence
DAA221
SUMO1/sentrin/SMT3 specific peptidase 3
Molecular
brain
Human
SENP3
3.0% Decrease Gene Expression Level
DAA237
transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)
Molecular
brain
Human
TGM2
18.0% Increase Gene Expression Level
DAA227
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
Molecular
brain
Human
SMARCA2
3.0% Decrease Gene Expression Level
DAA233
synapsin II
Molecular
brain
Human
SYN2
29.0% Decrease Gene Expression Level
DAA234
synaptotagmin I
Molecular
brain
Human
SYT1
4.0% Decrease Gene Expression Level
DAA218
syndecan 2
Molecular
brain
Human
SDC2
25.0% Increase Gene Expression Level
DAA238
Thy-1 cell surface antigen
Molecular
brain
Human
THY1
7.0% Decrease Gene Expression Level
DAA239
translocase of inner mitochondrial membrane 17 homolog A (yeast)
Molecular
brain
Human
TIMM17A
13.0% Decrease Gene Expression Level
DAA205
tripartite motif-containing 27
Molecular
brain
Human
TRIM27
5.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA223 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member | Molecular | brain | Human | SERPINF1 | 7.0% Decrease Gene Expression Level | |
DAA216 | seryl-tRNA synthetase | Molecular | brain | Human | SARS | 10.0% Decrease Gene Expression Level | |
DAA236 | transcription factor 12 | Molecular | brain | Human | TCF12 | 7.0% Increase Gene Expression Level | |
DAA217 | sodium channel, voltage-gated, type II, beta | Molecular | brain | Human | SCN2B | 50.0% Decrease Gene Expression Level | |
DAA225 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 | Molecular | brain | Human | SLC17A7 | 9.0% Decrease Gene Expression Level | |
DAA226 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Molecular | brain | Human | SLC25A4 | 9.0% Decrease Gene Expression Level | |
DAA166 | solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene 1 | Molecular | brain | Human | SLC2A3P1 | 17.0% Decrease Gene Expression Level | |
DAA228 | sorting nexin 3 | Molecular | brain | Human | SNX3 | 5.0% Decrease Gene Expression Level | |
DAA766 | Speech production problems | Psychological | brain | Human | — | — | |
DAA224 | S-phase kinase-associated protein 1 | Molecular | brain | Human | SKP1 | 4.0% Decrease Gene Expression Level | |
DAA67 | sphingosine-1-phosphate receptor 1 | Molecular | brain | Human | S1PR1 | 27.0% Increase Gene Expression Level | |
DAA230 | spondin 1, extracellular matrix protein | Molecular | brain | Human | SPON1 | 21.0% Increase Gene Expression Level | |
DAA231 | stathmin-like 2 | Molecular | brain | Human | STMN2 | 6.0% Decrease Gene Expression Level | |
DAA627 | Stroke | Pathological | brain | Human | — | SeriesMorbidity | |
DAA1027 | Stroke (Female) | Pathological | brain | Human | — | SeriesIncidence | |
DAA1026 | Stroke (Male) | Pathological | brain | Human | — | SeriesIncidence | |
DAA221 | SUMO1/sentrin/SMT3 specific peptidase 3 | Molecular | brain | Human | SENP3 | 3.0% Decrease Gene Expression Level | |
DAA237 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | Molecular | brain | Human | TGM2 | 18.0% Increase Gene Expression Level | |
DAA227 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | Molecular | brain | Human | SMARCA2 | 3.0% Decrease Gene Expression Level | |
DAA233 | synapsin II | Molecular | brain | Human | SYN2 | 29.0% Decrease Gene Expression Level | |
DAA234 | synaptotagmin I | Molecular | brain | Human | SYT1 | 4.0% Decrease Gene Expression Level | |
DAA218 | syndecan 2 | Molecular | brain | Human | SDC2 | 25.0% Increase Gene Expression Level | |
DAA238 | Thy-1 cell surface antigen | Molecular | brain | Human | THY1 | 7.0% Decrease Gene Expression Level | |
DAA239 | translocase of inner mitochondrial membrane 17 homolog A (yeast) | Molecular | brain | Human | TIMM17A | 13.0% Decrease Gene Expression Level | |
DAA205 | tripartite motif-containing 27 | Molecular | brain | Human | TRIM27 | 5.0% Decrease Gene Expression Level |